Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
Source: prnewswire.com